INDFF yields 2.58% · PFE yields 6.20%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, INDFF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of INDFF + PFE for your $10,000?
Indofood Agri Resources Ltd., together with its subsidiaries, operates as a vertically integrated agribusiness company in Singapore, Indonesia, China, Nigeria, Timor Leste, Germany, the Philippines, Myanmar, and internationally. It engages in the research and development; oil palm seed breeding; oil palm cultivation and milling; crude palm oil production and refining; rubber, sugar cane, cocoa, and tea cultivation; and industrial timber plantation activities. The company operates in two segments, Plantations, and Edible Oils and Fats. The Plantations segment is involved in the development and maintenance of oil palm, rubber, and sugar cane plantations; and other business activities relating to processing, marketing, and selling palm oil, rubber, and sugar cane. The Edible Oils and Fats segment produces, markets, and sells edible oil, margarine, shortening, and other related products, as well as its derivative products. It offers cooking oil under the Bimoli, Bimoli Spesial, Delima, Amanda, and Happy brands; and margarine and shortening products under the Amanda, Palmia, Royal Palmia, Simas, Malinda, and Delima brands. As of December 31, 2021, the company had a planted area of approximately 300,749 hectares, including 250,615 hectares of oil palm; 16,228 hectares of rubber; 14,411 hectares of sugar cane; and 19,495 hectares of other crops. It also owns and operates bulking facilities; provides transportation, investment, management, and technical services; and operates in the macronutrients mix fertilizers and prefabrication industries. The company was incorporated in 2001 and is headquartered in Singapore. Indofood Agri Resources Ltd. is a subsidiary of Indofood Singapore Holdings Pte. Ltd.
Full INDFF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.